Candesartan Cilexetil
Product Images NDC 49884-661

6 FDA label images from Par Pharmaceutical Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil (NDC 49884-661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of candesartan cilexetil showing its molecular framework and indicating the site of ester hydrolysis.*
FDA Label Image

Figure 1 Graph (Image 02)

Figure 1 Graph (Image 02)
A forest plot displaying hazard ratios with 95% confidence intervals for various patient subgroups comparing the effectiveness of candesartan cilexetil versus placebo. Subgroups include demographic factors (age, sex, race), clinical classifications (NYHA class, LVEF), and medical history or concurrent treatments. The plot visualizes whether candesartan cilexetil or placebo is favored across these groups.*
FDA Label Image

Candesartan Cilexetil 4 mg 90 Count Bottle Label (Image 03)

Candesartan Cilexetil 4 mg 90 Count Bottle Label (Image 03)
Label for Candesartan Cilexetil 4 mg tablets, containing 90 tablets. The product is manufactured by AstraZeneca AB and Par Pharmaceutical Inc., with printing indicating product origins in Sweden, the U.S., and Italy. The label includes NDC 49884-658-09 and states 'Rx only.'*
FDA Label Image

Candesartan Cilexetil 8 mg 90 Count Bottle Label (Image 04)

Candesartan Cilexetil 8 mg 90 Count Bottle Label (Image 04)
Packaging label for Candesartan Cilexetil 8 mg tablets. The label indicates a quantity of 90 tablets, prescription only. Manufactured by Par Pharmaceutical Inc. under license from AstraZeneca AB, Sweden. Product origin listed as Italy, with identifiable NDC 49884-659-09.*
FDA Label Image

Candesartan Cilexetil 16 mg 90 Count Bottle Label (Image 05)

Candesartan Cilexetil 16 mg 90 Count Bottle Label (Image 05)
Label for Candesartan Cilexetil 16 mg tablets by Par Pharmaceutical Inc., showing a package size of 90 tablets. The label includes the NDC number 49884-660-09 and notes the product is manufactured by AstraZeneca AB, Sweden, and labeled for Par Pharmaceutical in the USA. The label also displays the Par Pharmaceutical logo.*
FDA Label Image

Candesartan Cilexetil 32 mg 90 Count Bottle Label (Image 06)

Candesartan Cilexetil 32 mg 90 Count Bottle Label (Image 06)
Label of Candesartan cilexetil 32 mg tablets, containing 90 tablets. The product is Rx only and is manufactured by AstraZeneca AB, Sweden, and Par Pharmaceutical in Chestnut Ridge, New York, USA. The label features branding for PAR Pharmaceutical Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.